GooglePills - Common Cold - GEMINI 3.0 WITH PHYTOINTELLIGENCE 1.9 MASTER RESEARCH PROTOCOL TARGETED MODULATION OF RHINOVIRUS-INDUCED PRO-INFLAMMATORY CASCADES

The common cold, primarily driven by Human Rhinovirus (HRV) serotypes, represents a significant burden on global morbidity and economic productivity. Conventional pharmacotherapy remains largely palliative. This protocol delineates the PhytoIntelligence 1.9 framework, a computational and biological validation pipeline designed to optimize phytochemical interventions. The proposed theoretical framework posits that a synergistic stack of standardized bioactives can concurrently inhibit viral replication via 3C-protease blockade, modulate the NF-κB signalosome to reduce cytokine storm, and enhance barrier integrity in respiratory epithelia. This document provides an exhaustive pathophysiological review, derivation of Compound Efficacy Scores (CES), Loewe Additivity synergy modeling, and a rigorous formulation strategy. The projected outcome is a non-toxic, broad-spectrum antiviral therapeutic capable of reducing viral titers by >1.5 log10 and suppressing IL-6/IL-8 secretion by >40% in A549 alveolar basal epithelial models.